Efficacy of apixaban in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective observational study
Latest Information Update: 09 Jul 2021
At a glance
- Drugs Apixaban (Primary)
- Indications Stroke; Thromboembolism; Transient ischaemic attacks
- Focus Adverse reactions; Therapeutic Use
- 09 Jul 2021 New trial record
- 11 Jun 2021 Primary endpoint of thromboembolic events (stroke/transient ischemic attack or systemic embolism) has not been met, according to results published in the Medicine.
- 11 Jun 2021 Results published in the Medicine